Ali Jalili

1.6k total citations
83 papers, 1.3k citations indexed

About

Ali Jalili is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Ali Jalili has authored 83 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Immunology, 21 papers in Oncology and 20 papers in Molecular Biology. Recurrent topics in Ali Jalili's work include Immunotherapy and Immune Responses (10 papers), Mesenchymal stem cell research (8 papers) and Cytokine Signaling Pathways and Interactions (7 papers). Ali Jalili is often cited by papers focused on Immunotherapy and Immune Responses (10 papers), Mesenchymal stem cell research (8 papers) and Cytokine Signaling Pathways and Interactions (7 papers). Ali Jalili collaborates with scholars based in Iran, Canada and United States. Ali Jalili's co-authors include Anna Janowska‐Wieczorek, Neeta Shirvaikar, Leah A. Marquez‐Curtis, Mohammad Reza Rahmani, Yu Wang, Zhenhua Miao, Mark E.T. Penfold, Juan C. Jaén, Robert Berahovich and Penglie Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The Journal of Immunology.

In The Last Decade

Ali Jalili

82 papers receiving 1.2k citations

Peers

Ali Jalili
T. O'Reilly Switzerland
Yuan Cao China
Pia Isomäki Finland
Mazdak Ganjalıkhani-Hakemi Iran
Maria C. Lebre Netherlands
Aleksander M. Grabiec Poland
Diego Mourão‐Sá United Kingdom
Stephen H. Benedict United States
T. O'Reilly Switzerland
Ali Jalili
Citations per year, relative to Ali Jalili Ali Jalili (= 1×) peers T. O'Reilly

Countries citing papers authored by Ali Jalili

Since Specialization
Citations

This map shows the geographic impact of Ali Jalili's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Jalili with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Jalili more than expected).

Fields of papers citing papers by Ali Jalili

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ali Jalili. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Jalili. The network helps show where Ali Jalili may publish in the future.

Co-authorship network of co-authors of Ali Jalili

This figure shows the co-authorship network connecting the top 25 collaborators of Ali Jalili. A scholar is included among the top collaborators of Ali Jalili based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ali Jalili. Ali Jalili is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jalili, Ali, et al.. (2024). Decellularized skin pretreatment by monophosphoryl lipid A and lactobacillus casei supernatant accelerate skin recellularization. Molecular Biology Reports. 51(1). 675–675. 2 indexed citations
2.
Soleimani, Farzad, et al.. (2023). The Disruption of Mage-11 Gene via CRISPR/Cas9 Method Induced Apoptosis in the in vitro Model of Prostate Cancer.. PubMed. 1(41). 7–16. 1 indexed citations
3.
Khayrullin, Mars, et al.. (2021). T‐cell immunoglobulin and ITIM domain, as a potential immune checkpoint target for immunotherapy of colorectal cancer. IUBMB Life. 73(5). 726–738. 36 indexed citations
4.
Bandarian, Fatemeh, Farideh Razi, Hossein Adibi, et al.. (2021). An overview of diabetes research achievements during a quarter of a century in Diabetes Research Center. Journal of Diabetes & Metabolic Disorders. 23(2). 1809–1816. 2 indexed citations
5.
Ranjbar, Mohammad Mehdi, Fardin Fathi, Ali Jalili, et al.. (2020). Construction of A Synthetic Gene Encoding the Multi-Epitope of Toxoplasma gondii and Demonstration of the Relevant Recombinant Protein Production: A Vaccine Candidate. Galen Medical Journal. 9. e1708–e1708. 9 indexed citations
6.
7.
Sharifi, Mohammadreza, et al.. (2019). <p>Knockout Of <em>BIRC5</em> Gene By CRISPR/Cas9 Induces Apoptosis And Inhibits Cell Proliferation In Leukemic Cell Lines, HL60 And KG1</p>. SHILAP Revista de lepidopterología. Volume 9. 53–61. 19 indexed citations
8.
Fattahi, Nima, et al.. (2018). Prevalence of non-alcoholic Fatty Liver Disease in Kurdistan province, Iran, 2013 – 2014: A Population Based Study. GOVARESH. 23(2). 107–113. 2 indexed citations
9.
Dehghan, Hamidreza, et al.. (2017). Effect of Education on Preventive Treatment of Prostate Cancer in men Over 40 Years of Yazd on the Health Belief Model. SHILAP Revista de lepidopterología. 1 indexed citations
10.
Dehkordi, Korosh Ashrafi, Morteza Hashemzadeh Chaleshtori, Mohammadreza Sharifi, et al.. (2016). Inhibition of MicroRNA miR-222 with LNA Inhibitor Can Reduce Cell Proliferation in B Chronic Lymphoblastic Leukemia. Indian Journal of Hematology and Blood Transfusion. 33(3). 327–332. 10 indexed citations
11.
Jalili, Ali, et al.. (2015). The relationship between blood groups and âtype Aâ personality. Der pharmacia lettre. 7(9). 35–39. 1 indexed citations
12.
Nikkhoo, Bahram, et al.. (2014). Nuclear Pattern of CXCR4 Expression Is Associated with a Better Overall Survival in Patients with Gastric Cancer. Journal of Oncology. 2014. 1–7. 18 indexed citations
13.
Kazemi, Toba, et al.. (2013). Evaluation of cardiac function in patients with major beta thalassemia in Birjand. Scientific Journal of Iran Blood Transfus Organ. 10(1). 86–92. 1 indexed citations
14.
Jalili, Ali, et al.. (2012). CYTOKINES' LEVEL IN ACUTE AND CHRONIC BRUCELLOSIS PATIENTS. The Horizon of Medical Sciences. 18(357). 115–120. 2 indexed citations
15.
Jalili, Ali, et al.. (2010). DISRUPTION OF STROMAL-DERIVED FACTOR-1/CHEMOKINE RECEPTOR 4 BY SIMVASTATIN. 4(1). 1–7. 1 indexed citations
16.
Jalili, Ali, Neeta Shirvaikar, Leah A. Marquez‐Curtis, et al.. (2010). Fifth complement cascade protein (C5) cleavage fragments disrupt the SDF-1/CXCR4 axis: Further evidence that innate immunity orchestrates the mobilization of hematopoietic stem/progenitor cells. Experimental Hematology. 38(4). 321–332. 58 indexed citations
17.
Zabel, Brian A., Yu Wang, Susanna Lewén, et al.. (2009). Elucidation of CXCR7-Mediated Signaling Events and Inhibition of CXCR4-Mediated Tumor Cell Transendothelial Migration by CXCR7 Ligands. The Journal of Immunology. 183(5). 3204–3211. 245 indexed citations
18.
Wang, Wei, Yasuhiko Nishioka, Shuji Ozaki, et al.. (2008). HM1.24 (CD317) is a novel target against lung cancer for immunotherapy using anti-HM1.24 antibody. Cancer Immunology Immunotherapy. 58(6). 967–976. 54 indexed citations
19.
Hirose, Masao, Eiji Hosoi, Shuichi Hamano, & Ali Jalili. (2003). Multidrug resistance in hematological malignancy.. PubMed. 50(3-4). 126–35. 38 indexed citations
20.
Jalili, Ali. (1997). PSYCHIATRIC DISORDERS IN AN IRANIAN RURAL POPULATION. SHILAP Revista de lepidopterología. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by T. O'Reilly Breakdown of academic impact, for papers by Yuan Cao Breakdown of academic impact, for papers by Pia Isomäki Breakdown of academic impact, for papers by Mazdak Ganjalıkhani-Hakemi Breakdown of academic impact, for papers by Maria C. Lebre Breakdown of academic impact, for papers by Aleksander M. Grabiec Breakdown of academic impact, for papers by Diego Mourão‐Sá Breakdown of academic impact, for papers by Stephen H. Benedict
Rankless by CCL
2026